ADALIMUMAB-AACF

ADALIMUMAB-AACF was reported 335 times

ADALIMUMAB-AACF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UNEXPECTED VAGINAL BLEEDING ON HORMONAL IUD 1 0.0588
1 OESOPHAGOGASTROSCOPY 1 0.0556
2 REACTIVE GASTROPATHY 9 0.0235
3 ABORTION EARLY 2 0.0185
4 VENA CAVA EMBOLISM 1 0.0159
5 AXIAL SPONDYLOARTHRITIS 11 0.0125
6 EAR, NOSE AND THROAT INFECTION 1 0.0122
7 ONYCHOMALACIA 1 0.0080
8 BLOOD TESTOSTERONE FREE DECREASED 1 0.0076
9 POUCHITIS 6 0.0070
10 AGORAPHOBIA 8 0.0058
11 VACCINATION SITE SWELLING 1 0.0058
12 BILIARY CYST 1 0.0057
13 INTERCOSTAL NEURALGIA 1 0.0056
14 VERTEBRAL FORAMINAL STENOSIS 4 0.0049
15 CRYSTAL ARTHROPATHY 1 0.0048
16 FUNGAL PHARYNGITIS 1 0.0040
17 MINERAL DEFICIENCY 1 0.0036
18 SKIN OPERATION 1 0.0032
19 NODAL OSTEOARTHRITIS 1 0.0031
20 THROMBECTOMY 1 0.0031
21 LIPOPROTEIN (A) INCREASED 1 0.0031
22 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
23 DRUG-GENETIC INTERACTION 1 0.0028
24 NASAL TURBINATE HYPERTROPHY 1 0.0027
25 HAEMORRHOID OPERATION 1 0.0022
26 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
27 OESOPHAGEAL ADENOCARCINOMA 1 0.0021
28 PANIC DISORDER 8 0.0021
29 ANAL STENOSIS 1 0.0019
30 SOFT TISSUE SWELLING 1 0.0018
31 SPONDYLOARTHROPATHY 1 0.0017
32 LOSS OF THERAPEUTIC RESPONSE 5 0.0016
33 GLIOMA 1 0.0016
34 NASAL OPERATION 1 0.0015
35 MYOFASCIAL PAIN SYNDROME 1 0.0014
36 IMMUNISATION REACTION 1 0.0014
37 MUTISM 2 0.0014
38 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
39 LOCAL REACTION 1 0.0013
40 SUPERINFECTION BACTERIAL 1 0.0013
41 MYOPIA 3 0.0013
42 GUTTATE PSORIASIS 1 0.0012
43 ADENOMA BENIGN 1 0.0012
44 LARGE INTESTINE POLYP 8 0.0012
45 UTERINE POLYP 2 0.0011
46 APPLICATION SITE BRUISE 1 0.0010
47 LARGE INTESTINAL STENOSIS 2 0.0010
48 DEFAECATION URGENCY 7 0.0010
49 ONYCHALGIA 1 0.0010
50 DROWNING 1 0.0010
51 BREAST ABSCESS 1 0.0010
52 VASCULAR CALCIFICATION 1 0.0009
53 SPINAL OSTEOARTHRITIS 8 0.0009
54 PERIRECTAL ABSCESS 1 0.0009
55 HERPES VIRUS INFECTION 5 0.0009
56 FEBRILE INFECTION 1 0.0008
57 RADIUS FRACTURE 2 0.0008
58 MALIGNANT MELANOMA IN SITU 1 0.0008
59 FISTULA DISCHARGE 1 0.0008
60 PSORIATIC ARTHROPATHY 32 0.0008
61 CALCULUS BLADDER 1 0.0007
62 CLUSTER HEADACHE 1 0.0007
63 MYELITIS TRANSVERSE 1 0.0007
64 RENAL INFARCT 1 0.0007
65 GROIN PAIN 6 0.0007
66 PNEUMONIA PNEUMOCOCCAL 1 0.0007
67 ANAL INCONTINENCE 6 0.0007
68 UVEITIS 9 0.0007
69 CYSTITIS INTERSTITIAL 1 0.0006
70 INJECTION RELATED REACTION 1 0.0006
71 RECTAL ABSCESS 1 0.0006
72 ALOPECIA AREATA 1 0.0006
73 BREAST CYST 1 0.0006
74 OPHTHALMIC HERPES ZOSTER 1 0.0006
75 SINUS NODE DYSFUNCTION 1 0.0005
76 BODY TEMPERATURE ABNORMAL 1 0.0005
77 VITRITIS 1 0.0005
78 ADENOCARCINOMA OF COLON 1 0.0005
79 ARTERIAL DISORDER 1 0.0005
80 NIPPLE PAIN 1 0.0005
81 BODY TEMPERATURE FLUCTUATION 1 0.0005
82 ROTATOR CUFF SYNDROME 6 0.0005
83 INJECTION SITE INDENTATION 1 0.0005
84 SMALL INTESTINE CARCINOMA 1 0.0004
85 FREQUENT BOWEL MOVEMENTS 12 0.0004
86 VASCULAR DEVICE INFECTION 2 0.0004
87 HAEMANGIOMA 1 0.0004
88 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
89 CARTILAGE INJURY 1 0.0004
90 ARTHROPOD BITE 3 0.0004
91 LIPOMA 1 0.0004
92 RENAL CYST 3 0.0004
93 RHEUMATOID NODULE 1 0.0004
94 DEAFNESS UNILATERAL 2 0.0004
95 PLEURITIC PAIN 1 0.0004
96 NECK MASS 1 0.0004
97 JOINT LOCK 1 0.0004
98 ABORTION 1 0.0003
99 PULMONARY PAIN 1 0.0003
100 HIDRADENITIS 3 0.0003
101 HAEMATOCHEZIA 18 0.0003
102 FAMILY STRESS 1 0.0003
103 ORAL HERPES 6 0.0003
104 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
105 LEFT VENTRICULAR FAILURE 1 0.0003
106 FAECES SOFT 2 0.0003
107 UTERINE LEIOMYOMA 2 0.0003
108 PARADOXICAL DRUG REACTION 1 0.0003
109 PROTEIN TOTAL DECREASED 1 0.0003
110 GALLBLADDER OPERATION 1 0.0002
111 COLITIS ULCERATIVE 11 0.0002
112 PHARYNGITIS 3 0.0002
113 INTESTINAL STENOSIS 1 0.0002
114 PULMONARY TUBERCULOSIS 1 0.0002
115 DEVICE OPERATIONAL ISSUE 1 0.0002
116 ONYCHOMYCOSIS 1 0.0002
117 ANKYLOSING SPONDYLITIS 3 0.0002
118 IMMUNOSUPPRESSION 2 0.0002
119 GASTROINTESTINAL INFECTION 2 0.0002
120 HAEMOGLOBIN INCREASED 1 0.0002
121 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
122 SYNOVIAL CYST 1 0.0002
123 INTESTINAL OBSTRUCTION 8 0.0002
124 LIMB OPERATION 1 0.0002
125 CEREBRAL INFARCTION 5 0.0002
126 ERYSIPELAS 1 0.0002
127 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
128 ENDOCARDITIS 1 0.0002
129 PRODUCT COLOUR ISSUE 1 0.0002
130 THERAPY PARTIAL RESPONDER 3 0.0002
131 POLYARTHRITIS 1 0.0002
132 INJECTION SITE DISCHARGE 1 0.0002
133 ANAL ABSCESS 1 0.0002
134 FAECALOMA 1 0.0002
135 GASTROINTESTINAL PAIN 2 0.0002
136 NECROSIS 1 0.0002
137 SKIN INFECTION 2 0.0002
138 CANDIDA INFECTION 3 0.0002
139 HYPERTRIGLYCERIDAEMIA 1 0.0002
140 SPINAL PAIN 2 0.0002
141 PLEURISY 1 0.0002
142 ODYNOPHAGIA 1 0.0002
143 DERMATITIS ALLERGIC 2 0.0002
144 ENTERITIS 1 0.0002
145 PROCTALGIA 1 0.0002
146 HIATUS HERNIA 2 0.0002
147 POST-TRAUMATIC STRESS DISORDER 1 0.0001
148 METASTASES TO LYMPH NODES 1 0.0001
149 WRONG PRODUCT ADMINISTERED 1 0.0001
150 TASTE DISORDER 3 0.0001
151 INFLUENZA LIKE ILLNESS 12 0.0001
152 RESPIRATION ABNORMAL 1 0.0001
153 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
154 HYPERTHYROIDISM 2 0.0001
155 RASH PUSTULAR 1 0.0001
156 BLINDNESS TRANSIENT 1 0.0001
157 PAROSMIA 1 0.0001
158 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
159 CONCUSSION 1 0.0001
160 APHTHOUS ULCER 1 0.0001
161 BRAIN FOG 2 0.0001
162 ATRIAL FLUTTER 1 0.0001
163 FIBROMYALGIA 3 0.0001
164 ABNORMAL FAECES 1 0.0001
165 MENSTRUAL DISORDER 1 0.0001
166 HEMIPLEGIA 1 0.0001
167 LIVE BIRTH 1 0.0001
168 HEMIPARESIS 2 0.0001
169 METASTASES TO LIVER 2 0.0001
170 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
171 LUPUS-LIKE SYNDROME 1 0.0001
172 PATHOGEN RESISTANCE 1 0.0001
173 PNEUMONIA BACTERIAL 1 0.0001
174 IRON DEFICIENCY ANAEMIA 1 0.0001
175 PRODUCT DISTRIBUTION ISSUE 1 0.0001
176 NEPHROPATHY 1 0.0001
177 SQUAMOUS CELL CARCINOMA 1 0.0001
178 RHEUMATOID ARTHRITIS 12 0.0001
179 SPUTUM DISCOLOURED 1 0.0001
180 INTENTIONAL DOSE OMISSION 3 0.0001
181 HYPERCHOLESTEROLAEMIA 1 0.0001
182 ATELECTASIS 1 0.0001
183 ATRIAL FIBRILLATION 10 0.0001
184 AUTOIMMUNE DISORDER 1 0.0001
185 THERAPY CHANGE 1 0.0001
186 BLOOD PRESSURE ABNORMAL 2 0.0001
187 DRUG LEVEL DECREASED 1 0.0001
188 TOOTH ABSCESS 1 0.0001
189 TEMPERATURE INTOLERANCE 1 0.0001
190 POOR VENOUS ACCESS 1 0.0001
191 VENTRICULAR EXTRASYSTOLES 1 0.0001
192 ASPIRATION 1 0.0001
193 HYPERTENSIVE CRISIS 1 0.0001
194 PANCREATITIS ACUTE 2 0.0001
195 FISTULA 1 0.0001
196 MITRAL VALVE INCOMPETENCE 1 0.0001
197 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
198 PRODUCT SUBSTITUTION ISSUE 5 0.0001
199 ABDOMINAL PAIN 20 0.0001
200 CAESAREAN SECTION 1 0.0001
201 BLOOD IRON DECREASED 1 0.0001
202 WRIST FRACTURE 1 0.0001
203 LOCALISED INFECTION 2 0.0001
204 INJECTION SITE URTICARIA 2 0.0001
205 CYST 1 0.0001
206 INJECTION SITE DISCOLOURATION 1 0.0001
207 COLITIS 3 0.0001
208 HEPATIC CYTOLYSIS 1 0.0001
209 ERECTILE DYSFUNCTION 2 0.0001
210 INFUSION SITE PAIN 1 0.0001
211 QUALITY OF LIFE DECREASED 1 0.0001
212 GINGIVAL BLEEDING 1 0.0001
213 LUNG NEOPLASM MALIGNANT 3 0.0001
214 MASS 1 0.0001
215 CARPAL TUNNEL SYNDROME 1 0.0001
216 OSTEOARTHRITIS 3 0.0001
217 INJECTION SITE HAEMATOMA 1 0.0001
218 GASTROENTERITIS 1 0.0001
219 RENAL INJURY 2 0.0001
220 PULMONARY MASS 1 0.0001
221 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
222 OSTEOPENIA 1 0.0001
223 DEVICE FAILURE 1 0.0001
224 BLOOD PRESSURE INCREASED 10 0.0001
225 NASOPHARYNGITIS 12 0.0001
226 BASAL CELL CARCINOMA 1 0.0001
227 MENINGIOMA 1 0.0001
228 SWOLLEN TONGUE 2 0.0001
229 INJECTION SITE HAEMORRHAGE 5 0.0001
230 BACK DISORDER 1 0.0001
231 PHOTOSENSITIVITY REACTION 1 0.0001
232 FUNGAL INFECTION 2 0.0001
233 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
234 THERAPY CESSATION 3 0.0001
235 SCAR 1 0.0001
236 INJECTION SITE REACTION 4 0.0001
237 COLD SWEAT 1 0.0001
238 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
239 ISCHAEMIC STROKE 1 0.0001
240 GASTROENTERITIS VIRAL 1 0.0001
241 TOOTHACHE 1 0.0001
242 CONJUNCTIVITIS 1 0.0001
243 HEPATIC STEATOSIS 1 0.0001
244 PSORIASIS 7 0.0001
245 EPISTAXIS 4 0.0001
246 ABDOMINAL PAIN UPPER 11 0.0001
247 BLOOD SODIUM DECREASED 1 0.0001
248 FOOT FRACTURE 1 0.0001
249 PULMONARY FIBROSIS 1 0.0001
250 ACUTE RESPIRATORY FAILURE 1 0.0001
251 GLAUCOMA 1 0.0001
252 ERUCTATION 1 0.0001
253 DYSPHONIA 3 0.0001
254 ARTHRITIS 4 0.0001
255 DIARRHOEA 32 0.0000
256 DYSKINESIA 2 0.0000
257 INJECTION SITE PAIN 15 0.0000
258 PULMONARY HYPERTENSION 1 0.0000
259 BACK PAIN 11 0.0000
260 RECTAL HAEMORRHAGE 2 0.0000
261 POOR QUALITY SLEEP 1 0.0000
262 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
263 PERIPHERAL SWELLING 7 0.0000
264 APPLICATION SITE PAIN 1 0.0000
265 ANGIOEDEMA 2 0.0000
266 TOOTH DISORDER 1 0.0000
267 SNEEZING 1 0.0000
268 THERAPY NON-RESPONDER 2 0.0000
269 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
270 TINNITUS 2 0.0000
271 SKIN DISCOLOURATION 2 0.0000
272 ARRHYTHMIA 2 0.0000
273 THERAPY INTERRUPTED 3 0.0000
274 MIGRAINE 4 0.0000
275 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
276 PRESYNCOPE 1 0.0000
277 NEURALGIA 1 0.0000
278 PRODUCT DOSE OMISSION ISSUE 12 0.0000
279 COVID-19 7 0.0000
280 HAEMATOMA 1 0.0000
281 EXPOSURE VIA SKIN CONTACT 1 0.0000
282 RESPIRATORY TRACT INFECTION 1 0.0000
283 ECZEMA 2 0.0000
284 SEDATION 1 0.0000
285 MUSCULOSKELETAL PAIN 2 0.0000
286 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
287 FEAR 1 0.0000
288 RASH PRURITIC 2 0.0000
289 SKIN LESION 1 0.0000
290 ANAPHYLACTIC REACTION 2 0.0000
291 FEELING COLD 1 0.0000
292 MYALGIA 6 0.0000
293 FLATULENCE 2 0.0000
294 URINARY TRACT INFECTION 6 0.0000
295 ANXIETY 10 0.0000
296 RED BLOOD CELL COUNT DECREASED 1 0.0000
297 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
298 URINARY INCONTINENCE 1 0.0000
299 ARTHRALGIA 14 0.0000
300 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
301 BLOOD POTASSIUM DECREASED 1 0.0000
302 CONDITION AGGRAVATED 10 0.0000
303 INJECTION SITE RASH 1 0.0000
304 GYNAECOMASTIA 1 0.0000
305 EXPOSURE DURING PREGNANCY 2 0.0000
306 DRUG-INDUCED LIVER INJURY 1 0.0000
307 PULMONARY EMBOLISM 3 0.0000
308 MOOD SWINGS 1 0.0000
309 HYPOTHYROIDISM 1 0.0000
310 METABOLIC ACIDOSIS 1 0.0000
311 MOVEMENT DISORDER 1 0.0000
312 NIGHT SWEATS 1 0.0000
313 INCORRECT DOSE ADMINISTERED 7 0.0000
314 IMPAIRED HEALING 1 0.0000
315 STAPHYLOCOCCAL INFECTION 1 0.0000
316 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
317 SKIN DISORDER 1 0.0000
318 GAIT INABILITY 1 0.0000
319 URTICARIA 5 0.0000
320 TYPE 2 DIABETES MELLITUS 1 0.0000
321 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
322 HEPATIC ENZYME INCREASED 2 0.0000
323 HAEMATURIA 1 0.0000
324 ABDOMINAL DISTENSION 3 0.0000
325 HEART RATE DECREASED 1 0.0000
326 LYMPHADENOPATHY 1 0.0000
327 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
328 PNEUMONIA 9 0.0000
329 VOMITING 13 0.0000
330 CONSTIPATION 6 0.0000
331 PANIC ATTACK 1 0.0000
332 INJECTION SITE MASS 1 0.0000
333 BRONCHITIS 2 0.0000
334 ASTHMA 3 0.0000
335 HOT FLUSH 2 0.0000
336 UNEVALUABLE EVENT 2 0.0000
337 INJECTION SITE SWELLING 2 0.0000
338 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
339 ABORTION SPONTANEOUS 1 0.0000
340 OSTEOPOROSIS 1 0.0000
341 ROAD TRAFFIC ACCIDENT 1 0.0000
342 CEREBROVASCULAR ACCIDENT 4 0.0000
343 DEVICE LEAKAGE 1 0.0000
344 SEPTIC SHOCK 1 0.0000
345 MENTAL DISORDER 1 0.0000
346 MUSCULOSKELETAL STIFFNESS 2 0.0000
347 PULMONARY OEDEMA 1 0.0000
348 GASTROINTESTINAL DISORDER 2 0.0000
349 THROAT IRRITATION 1 0.0000
350 NEPHROLITHIASIS 1 0.0000
351 MUSCLE SPASMS 4 0.0000
352 HYPOKALAEMIA 1 0.0000
353 OROPHARYNGEAL PAIN 2 0.0000
354 RENAL DISORDER 1 0.0000
355 BLOOD CHOLESTEROL INCREASED 1 0.0000
356 COGNITIVE DISORDER 1 0.0000
357 SWELLING 2 0.0000
358 DYSPHAGIA 2 0.0000
359 COLORECTAL CANCER 1 0.0000
360 PRURITUS 8 0.0000
361 CONTUSION 2 0.0000
362 INFECTION 3 0.0000
363 OFF LABEL USE 18 0.0000
364 LUNG DISORDER 1 0.0000
365 HEART RATE INCREASED 2 0.0000
366 DRY EYE 1 0.0000
367 CELLULITIS 1 0.0000
368 SINUSITIS 2 0.0000
369 HAEMOGLOBIN DECREASED 2 0.0000
370 ILLNESS 2 0.0000
371 INFLAMMATION 1 0.0000
372 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
373 NERVOUSNESS 1 0.0000
374 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
375 SEPSIS 2 0.0000
376 ABDOMINAL DISCOMFORT 3 0.0000
377 BLISTER 1 0.0000
378 SEIZURE 2 0.0000
379 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
380 BONE PAIN 1 0.0000
381 CHILLS 2 0.0000
382 SURGERY 1 0.0000
383 NASAL CONGESTION 1 0.0000
384 CATARACT 1 0.0000
385 FATIGUE 13 0.0000
386 JOINT SWELLING 2 0.0000
387 THERAPEUTIC RESPONSE DECREASED 1 0.0000
388 PLEURAL EFFUSION 1 0.0000
389 VERTIGO 1 0.0000
390 DISCOMFORT 1 0.0000
391 PAIN 10 0.0000
392 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
393 INJECTION SITE ERYTHEMA 2 0.0000
394 ALOPECIA 3 0.0000
395 RENAL FAILURE 2 0.0000
396 BLOOD PRESSURE DECREASED 1 0.0000
397 INJECTION SITE PRURITUS 1 0.0000
398 DRUG INEFFECTIVE 19 0.0000
399 HEADACHE 9 0.0000
400 COUGH 4 0.0000
401 BURNING SENSATION 1 0.0000
402 DEVICE MALFUNCTION 1 0.0000
403 HYPERTENSION 3 0.0000
404 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
405 SKIN BURNING SENSATION 1 0.0000
406 RASH 6 0.0000
407 PAIN IN EXTREMITY 4 0.0000
408 WEIGHT INCREASED 3 0.0000
409 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
410 DYSPNOEA 7 0.0000
411 RENAL IMPAIRMENT 1 0.0000
412 SKIN EXFOLIATION 1 0.0000
413 BALANCE DISORDER 1 0.0000
414 PYREXIA 4 0.0000
415 MALAISE 5 0.0000
416 TACHYCARDIA 1 0.0000
417 DEVICE ISSUE 1 0.0000
418 HYPERSENSITIVITY 2 0.0000
419 WEIGHT DECREASED 3 0.0000
420 CARDIAC DISORDER 1 0.0000
421 NEUROPATHY PERIPHERAL 1 0.0000
422 ANAEMIA 2 0.0000
423 GAIT DISTURBANCE 2 0.0000
424 DYSPEPSIA 1 0.0000
425 SYNCOPE 1 0.0000
426 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
427 FLUSHING 1 0.0000
428 CHEST DISCOMFORT 1 0.0000
429 FALL 3 0.0000
430 INFLUENZA 1 0.0000
431 MUSCULAR WEAKNESS 1 0.0000
432 PALPITATIONS 1 0.0000
433 DISEASE PROGRESSION 1 0.0000
434 OEDEMA PERIPHERAL 1 0.0000
435 VISUAL IMPAIRMENT 1 0.0000
436 ASTHENIA 3 0.0000
437 NAUSEA 6 0.0000
438 DEHYDRATION 1 0.0000
439 DRY SKIN 1 0.0000
440 VISION BLURRED 1 0.0000
441 MEMORY IMPAIRMENT 1 0.0000
442 HYPOAESTHESIA 1 0.0000
443 PARAESTHESIA 1 0.0000
444 DRUG INTERACTION 1 0.0000
445 DIZZINESS 3 0.0000
446 MYOCARDIAL INFARCTION 1 0.0000
447 CHEST PAIN 1 0.0000
448 PRODUCT USE ISSUE 1 0.0000
449 HYPOTENSION 1 0.0000
450 SOMNOLENCE 1 0.0000
451 ERYTHEMA 1 0.0000
452 DEPRESSION 1 0.0000
453 DECREASED APPETITE 1 0.0000
454 DEATH 2 0.0000